vm2: Incorrect Authorization
CVE-2026-100721 is a critical-severity incorrect authorization vulnerability in vm2 from Patriksimek, with a CVSS 3.1 base score of 9.0 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. The record lists version 3.12.2 as the first without the flaw, so updating vm2 to that release or later removes the exposure. There is no confirmed exploitation so far. EPSS estimates a 0.59% chance of exploitation within 30 days, which is low compared with other CVEs.
Critical severity: a successful attack would have severe impact.
What to do
- Update vm2 to 3.12.2 or a later version.
- Read the advisory on github.com for workarounds and exact fixed builds.
- Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| Patriksimek | vm2 | before 3.12.2 | 3.12.2 |
Version data comes from the organisation that assigned the CVE. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- NetworkCan be exploited remotely over a network, including the internet.
- Attack complexity
- HighSuccess depends on conditions outside the attacker's control.
- Privileges required
- NoneNo account or login is needed.
- User interaction
- NoneNo action by a victim is required.
- Scope
- ChangedThe attack can reach beyond the vulnerable component into other systems.
- Confidentiality
- HighAll data handled by the component can be read.
- Integrity
- HighData or code can be modified at will.
- Availability
- HighThe component can be taken down completely.
Vector: CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:H. Scored by CNA (vulncheck.com).
| Scoring system | Score | Severity | Scored by |
|---|---|---|---|
| CVSS 4.0 | 9.5 | Critical | CNA (vulncheck.com) |
| CVSS 3.1 | 9.0 | Critical | CNA (vulncheck.com) |
Official description
vm2 before 3.12.2 contains an authorization bypass in the NodeVM external-module resolver. When an embedder configures `require.external` with a custom resolver (and `context: 'host'`), `LegacyResolver.customResolve` in lib/resolver-compat.js records the resolved module directory in `this.externals` as `new RegExp('^' + escapeRegExp(resolvedPath))`, without requiring a path separator or end-of-string boundary. Untrusted guest code can therefore require the allowlisted module (e.g. `foo`) and then require the absolute path of a non-allowlisted sibling whose path merely shares the resolved prefix (e.g. `.../node_modules/foo2/index.js`); the sibling passes `isPathAllowedForModule` and is loaded through `hostRequire`, so its top-level code runs in the host process before the exports are wrapped with `vm.readonly`, resulting in a sandbox escape and arbitrary code execution in the host context.
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Incorrect Authorization
The product performs an authorization check when an actor attempts to access a resource or perform an action, but it does not correctly perform the check.
How developers prevent this class of flaw
- Divide the product into anonymous, normal, privileged, and administrative areas. Reduce the attack surface by carefully mapping roles with data and functionality. Use role-based access control (RBAC) to enforce the roles at the appropriate boundaries. Note that this approach may not protect against horizontal authorization, i.e., it will not protect a user from attacking others with the same role.
- Ensure that access control checks are performed related to the business logic. These checks may be different than the access control checks that are applied to more generic resources such as files, connections, processes, memory, and database records. For example, a database may restrict access for medical records to a specific database user, but each record might only be intended to be accessible to the patient and the patient's doctor.
- Use a vetted library or framework that does not allow this weakness to occur or provides constructs that make this weakness easier to avoid. For example, consider using authorization frameworks such as the JAAS Authorization Framework and the OWASP ESAPI Access Control feature.
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: poc, automatable: no, technical impact: total).
- Record last changed materially (score, affected products, status or references).
References
Patches and release notes
Other vulnerabilities in vm2
- 7.5 High severity
- 10.0 Critical severity
- 10.0 Critical severity
- 7.2 High severity
- 10.0 Critical severity
- 7.5 High severity
Recent Incorrect Authorization vulnerabilities
- 8.8 High severity
- 7.7 High severity
- 7.7 High severity
- 8.8 High severity
- 8.3 High severity
- 8.3 High severity
Spotted an error? Tell us.